BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 16706256)

  • 1. Population-based study of the relationship between patent foramen ovale and cerebrovascular ischemic events.
    Petty GW; Khandheria BK; Meissner I; Whisnant JP; Rocca WA; Christianson TJ; Sicks JD; O'Fallon WM; McClelland RL; Wiebers DO
    Mayo Clin Proc; 2006 May; 81(5):602-8. PubMed ID: 16706256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-based study of the relationship between atherosclerotic aortic debris and cerebrovascular ischemic events.
    Petty GW; Khandheria BK; Meissner I; Whisnant JP; Rocca WA; Sicks JD; Christianson TJ; O'Fallon WM; McClelland RL; Wiebers DO
    Mayo Clin Proc; 2006 May; 81(5):609-14. PubMed ID: 16706257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of recurrent cerebral ischemic events in patients with patent foramen ovale and cryptogenic strokes or transient ischemic attacks.
    Cujec B; Mainra R; Johnson DH
    Can J Cardiol; 1999 Jan; 15(1):57-64. PubMed ID: 10024860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of atrial septal abnormalities in older patients with cryptogenic ischemic stroke or transient ischemic attack.
    Force M; Massabuau P; Larrue V
    Clin Neurol Neurosurg; 2008 Sep; 110(8):779-83. PubMed ID: 18534743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age as a determinant of adverse events in medically treated cryptogenic stroke patients with patent foramen ovale.
    Homma S; DiTullio MR; Sacco RL; Sciacca RR; Mohr JP;
    Stroke; 2004 Sep; 35(9):2145-9. PubMed ID: 15232117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
    Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
    JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patent foramen ovale: innocent or guilty? Evidence from a prospective population-based study.
    Meissner I; Khandheria BK; Heit JA; Petty GW; Sheps SG; Schwartz GL; Whisnant JP; Wiebers DO; Covalt JL; Petterson TM; Christianson TJ; Agmon Y
    J Am Coll Cardiol; 2006 Jan; 47(2):440-5. PubMed ID: 16412874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevalence of structural abnormalities of the atrial septum and their association with recent ischemic stroke or transient ischemic attack: echocardiographic evaluation in 18631 patients].
    Serafini O; Misuraca G; Greco F; Bisignani G; Manes MT; Venneri N
    Ital Heart J Suppl; 2003 Jan; 4(1):39-45. PubMed ID: 12690933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study.
    Paciaroni M; Agnelli G; Bertolini A; Pezzini A; Padovani A; Caso V; Venti M; Alberti A; Palmiero RA; Cerrato P; Silvestrelli G; Lanari A; Previdi P; Corea F; Balducci A; Ferri R; Falcinelli F; Filippucci E; Chiocchi P; Grandi FC; Ferigo L; Musolino R; Bersano A; Ghione I; Sacco S; Carolei A; Baldi A; Ageno W;
    Cerebrovasc Dis; 2011; 31(2):109-16. PubMed ID: 21088390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke.
    Windecker S; Wahl A; Nedeltchev K; Arnold M; Schwerzmann M; Seiler C; Mattle HP; Meier B
    J Am Coll Cardiol; 2004 Aug; 44(4):750-8. PubMed ID: 15312853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does transesophageal echocardiographic demonstration of a patent foramen ovale in patients with a recent cerebral ischemic event change anticoagulation therapy?
    Boddicker KA; Kerber RE
    J Am Soc Echocardiogr; 2005 Apr; 18(4):357-61. PubMed ID: 15846164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack. French Study Group on Patent Foramen Ovale and Atrial Septal Aneurysm.
    Mas JL; Zuber M
    Am Heart J; 1995 Nov; 130(5):1083-8. PubMed ID: 7484740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphology of the patent foramen ovale in asymptomatic versus symptomatic (stroke or transient ischemic attack) patients.
    Goel SS; Tuzcu EM; Shishehbor MH; de Oliveira EI; Borek PP; Krasuski RA; Rodriguez LL; Kapadia SR
    Am J Cardiol; 2009 Jan; 103(1):124-9. PubMed ID: 19101242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary prevention after cryptogenic cerebrovascular events in patients with patent foramen ovale.
    Schuchlenz HW; Weihs W; Berghold A; Lechner A; Schmidt R
    Int J Cardiol; 2005 May; 101(1):77-82. PubMed ID: 15860387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atherosclerotic burden findings in young cryptogenic stroke patients with and without a patent foramen ovale.
    Rodés-Cabau J; Noël M; Marrero A; Rivest D; Mackey A; Houde C; Bédard E; Larose E; Verreault S; Peticlerc M; Pibarot P; Bogaty P; Bertrand OF
    Stroke; 2009 Feb; 40(2):419-25. PubMed ID: 19095992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of patent foramen ovale permitting paradoxic embolism.
    Hausmann D; Mügge A; Daniel WG
    J Am Coll Cardiol; 1995 Oct; 26(4):1030-8. PubMed ID: 7560596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of morphology of patent foramen ovale with transesophageal echocardiography in symptomatic and asymptomatic patients.
    Bayar N; Arslan Ş; Çağırcı G; Erkal Z; Üreyen ÇM; Çay S; Köklü E; Yüksel İÖ; Küçükseymen S
    J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1282-6. PubMed ID: 25906928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both.
    Mas JL; Arquizan C; Lamy C; Zuber M; Cabanes L; Derumeaux G; Coste J;
    N Engl J Med; 2001 Dec; 345(24):1740-6. PubMed ID: 11742048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of atrial fibrillation after percutaneous closure of patent foramen ovale and small atrial septal defects in patients presenting with cryptogenic stroke.
    Bonvini RF; Sztajzel R; Dorsaz PA; Righini M; Bonvin C; Alibegovic J; Sigwart U; Camenzind E; Verin V; Sztajzel J
    Int J Stroke; 2010 Feb; 5(1):4-9. PubMed ID: 20088986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography.
    Cabanes L; Mas JL; Cohen A; Amarenco P; Cabanes PA; Oubary P; Chedru F; Guérin F; Bousser MG; de Recondo J
    Stroke; 1993 Dec; 24(12):1865-73. PubMed ID: 8248969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.